341. [Side effect and supportive care to combination of gemcitabine and cisplatin chemotherapy for the advanced urothelial cancer].
作者: Yoichiro Kato.;Junya Sato.;Renpei Kato.;Ryo Takata.;Wataru Obara.
来源: Nihon Rinsho. 2015年73 Suppl 2卷609-13页 342. [Ovarian cancer: TC therapy].343. [Adverse event and countermeasure with regard to FOLFIRINOX for pancreatic cancer].
作者: Futa Koga.;Hideki Ueno.;Chigusa Morizane.;Shunsuke Kondo.;Yasunari Sakamoto.;Takuji Okusaka.
来源: Nihon Rinsho. 2015年73 Suppl 2卷597-603页 344. [Supportive management of cisplatin and gemcitabine combination therapy for advanced biliary tract cancer].345. [Incidence and management of adverse events in FOLFOX plus bevacizumab therapy for colorectal cancer].346. [S-1 plus cisplatin(SP) for advanced gastric cancer].347. [Strategies to minimize toxicities during chemoradiotherapy for esophageal cancer].348. [Concurrent chemoradiotherapy with cisplatin for locally advanced squamous cell carcinoma of head and neck].349. [Management of side effects with platinum doublet chemotherapy used for treatment of non-small cell lung cancer].351. [Secondary malignant neoplasms].352. [Safety management of infusion reactions].353. [Allergic reaction and anaphylaxis].354. [Chemotherapy related gonadotoxicity].
作者: Keiko Kamoshita.;Kouhei Sugimoto.;Aiko Okamoto.;Nao Suzuki.
来源: Nihon Rinsho. 2015年73 Suppl 2卷507-13页 356. [Rhabdomyolysis].357. [Drug-induced arthralgias and myalgias].358. [Corneal epithelial disorder, lacrimal drainage obstruction, and conjunctivitis].360. [Ototoxicity of cisplatin]. |